Active· since Mar 18, 2026
- 183
- days running
- 2
- relaunches
Ad copy
If you took Dupixent and were later diagnosed with lymphoma, you need to see this. Studies show Dupixent users face up to 30x higher reporting rates for T-cell lymphoma. The FDA placed it on its cancer watch list in 2025. Yet no cancer warning has been added to the label. You may be entitled to compensation. Claims are being filed now. Check your eligibility — free and confidential.
No label warning?!
This is a message for patients who took Dupixent for eczema, atopic dermatitis, or asthma and have been diagnosed with T-cell lymphoma. Specifically for Dupixent users diagnosed with Cutaneous T-Cell Lymphoma, Mycosis Fungoides, Sezary Syndrome, Peripheral T-Cell Lymphoma, or other T-cell lymphoma s...
Like this ad? Make it yours.
Crush rebuilds this exact creative around your product — your brand, your colors, your offer — in about a minute.
